BCR and chronic myelogenous leukemia, BCR-ABL1 positive: In our previous study, we investigated the anti-CML effects of 8-OHD, focusing on cell-cycle regulation, cell apoptosis, autophagy, differentiation, and the altered level of BCR-ABL in K562 cells [39].